The scope of the EU-funded ImmunoBioInks project (https://cordis.europa.eu/project/id/893099) is to develop 3D-printed materials to treat musculoskeletal defects in patients with an immune system imbalance. The idea is to combine self-assembling peptides and chemically modified hyaluronic acid into printable scaffolds of defined architecture and with carefully designed mechanical properties that can reprogram the patient’s own immune cells. The interaction of immune cells with this innovative 3D scaffold is expected to trigger the necessary healing response. Furthermore, we have recently expanded the scope of the project by an extended partnership part, entitled Space ImmunoBioInks, where we propose to study behaviour of self-assembling peptide-based bioinks, used for modulation of immune system cells, under microgravity with an ultimate future goal of providing novel biofabrication tools for studies in space.
The scope of the EU-funded ImmunoBioInks project (https://cordis.europa.eu/project/id/893099) is to develop 3D-printed materials to treat musculoskeletal defects in patients with an immune system imbalance. The idea is to combine self-assembling peptides and chemically modified hyaluronic acid into printable scaffolds of defined architecture and with carefully designed mechanical properties that can reprogram the patient’s own immune cells. The interaction of immune cells with this innovative 3D scaffold is expected to trigger the necessary healing response. Furthermore, we have recently expanded the scope of the project by an extended partnership part, entitled Space ImmunoBioInks, where we propose to study behaviour of self-assembling peptide-based bioinks, used for modulation of immune system cells, under microgravity with an ultimate future goal of providing novel biofabrication tools for studies in space.
Jacek Wychowaniec <jacek.wychowaniec@aofoundation.org>
Jacek Wychowaniec <jacek.wychowaniec@aofoundation.org>